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Spatiotemporal endothelial cell –  
pericyte association in tumors 
as shown by high resolution 4D 
intravital imaging
Ann L. B. Seynhaeve1, Douwe Oostinga1, Rien van Haperen2, Hanna M. Eilken3,  
Susanne Adams3, Ralf H. Adams  3 & Timo L. M. ten Hagen1
Endothelial cells and pericytes are integral cellular components of the vasculature with distinct 
interactive functionalities. To study dynamic interactions between these two cells we created two 
transgenic animal lines. A truncated eNOS (endothelial nitric oxide synthase) construct was used as a 
GFP tag for endothelial cell evaluation and an inducible Cre-lox recombination, under control of the 
Pdgfrb (platelet derived growth factor receptor beta) promoter, was created for pericyte assessment. 
Also, eNOStag-GFP animals were crossed with the already established Cspg4-DsRed mice expressing 
DsRed fluorescent protein in pericytes. For intravital imaging we used tumors implanted in the 
dorsal skinfold of these transgenic animals. This setup allowed us to study time and space dependent 
complexities, such as distribution, morphology, motility, and association between both vascular cell 
types in all angiogenetic stages, without the need for additional labeling. Moreover, as fluorescence was 
still clearly detectable after fixation, it is possible to perform comparative histology following intravital 
evaluation. These transgenic mouse lines form an excellent model to capture collective and individual 
cellular and subcellular endothelial cell – pericyte dynamics and will help answer key questions on the 
cellular and molecular relationship between these two cells.
Blood vessels consist of an endothelial lining surrounded by perivascular cells (i.e. pericytes and vascular smooth 
muscle cells). Endothelial cells form the inner layer sustaining a dynamic barrier between underlying tissue and 
blood. Perivascular cells are wrapped around endothelial cells, provide structural support to the vessel tube and 
regulate vascular tone, although the complex molecular association between both cells suggests that pericytes 
are more than just supporting cells (for review1,2). While presence of pericytes in the vasculature has been doc-
umented in the past and is reviewed by Simms in 19863, more intensive investigation into lineage4,5, function6, 
and motility7, especially in association with endothelial cells, is more recent as is recognition of a therapeutic 
target8–11. As pericytes express different markers and the expression profile varies between subtypes, species, 
tissue and pathological conditions12–17, it is a more challenging cell type to investigate. Angiogenesis, the for-
mation of new blood vessels from a pre-existing vascular network, is a very dynamic biological process which 
involves a series of interdependent and multicellular processes. In general it starts with sprouting of endothelial 
cells18,19 from existing vessels, followed by formation of a functional tube through anastomosis20, pruning21,22 and 
re-introduction of perivascular cells16,23. Depicting angiogenesis by classical histology provides a static image and 
is often not sufficient for a correct interpretation of kinetics as such spatiotemporal complexity requires successive 
observations in a 4D (XYZ spatial + T, time dimension) intravital manner. A major technological development 
which improved possibilities for longitudinal cellular investigation in vivo is the introduction of fluorescent pro-
teins to the genome of animals, most often mice and zebrafish24–26.
In this report we demonstrate the use of two transgenic mouse lines expressing fluorescent proteins in both 
endothelial cells and pericytes. We generated a transgenic mouse line using the eNOS (endothelial nitric oxide 
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synthase) promoter as a tag controlling GFP expression to evaluate endothelial cells, and a line with an induci-
ble Cre-lox recombination under control of the Pdgfrb (platelet derived growth factor receptor beta) promoter 
for assessment of pericytes. Another reliable marker for pericytes is Cspg4 (chondroitin sulfate proteoglycan 4) 
and we crossed our eNOStag-GFP mouse with the already established Cspg4-DsRed mouse line27. We used a 
tumor transplanted in the dorsal skinfold chamber as an angiogenic model in order to achieve high resolution 
4D intravital imaging and evaluated spatial, temporal and morphological interactions between endothelial cells 
and pericytes.
Results
Fluorescence in endothelial cells and pericytes. To explore endothelial – pericyte association eNOS-
tag-GFP mice were crossed with Cspg4-DsRed mice (Suppl. Fig. S1C). Both constitutive expressed fluorescent 
labels were clearly visible when imaged intravitally (Fig. 1A) and were homogeneously distributed throughout the 
tumor-associated vasculature (Suppl. Fig. S2A). Using a tumor as an angiogenic model has the advantage that in 
a single tumor all stages of tumor vessel development were observed: areas void of vessels (Suppl. Fig. S2A; yellow 
asterisk), progressing angiogenic vessels (Suppl. Fig. S2A; arrow) next to dense regions with an already established 
vasculature (Suppl. Fig. S2A; white asterisk) and destroyed vessels (Suppl. Fig. S2A; double white asterisk) iden-
tified by granulated cellular leftovers still fluorescent for GFP or DsRed. These leftovers are positive for TUNEL 
staining (Suppl. Fig. S2B; arrow) indicative of apoptosis. Established vessels showed the typical endothelial cob-
blestone like morphology that is also seen in 2D in vitro cultures using Huvecs. Expression of eNOStagged GFP 
was observed in the golgi (Fig. 1A; asterisk, Suppl. Fig. 2C; arrow) and cellular membrane (Fig. 1A; arrow), allow-
ing visualization of cell-cell contacts. DsRed fluorescence in pericytes was seen in the cellular body (Fig. 1B; aster-
isk) and in several processes protruding from the cellular body (Fig. 1B; arrow). Also, fluorescence in long thin 
endothelial sprouts (Fig. 1C; yellow arrowhead) and associated Cspg4+ pericytes was detected. Pericyte cellular 
bodies (Fig. 1C; asterisk) were thin with longer processes protruding from opposite sides of the body (Fig. 1C; 
white arrowhead). Secondly, eNOStag-GFP mice were crossed with an inducible Pdgfrb(BAC)-CreERT2xROSA-
tdTomato line, expressing tomato fluorescence in Pdgfrb+ cells after tamoxifen administration (Suppl. Fig. S1E). 
Distribution of labeled Pdgfrb+ pericytes was heterogeneously dispersed throughout the tumor, most likely as a 
result of more mosaic recombination, referred to as hotspots (Suppl. Fig. S2D; asterisk). Fluorescent expression 
and morphology of Pdgfrb+ cells in this mouse line (Fig. 1D) were similar to Cspg4+ cells. TdTomato fluores-
cence was seen throughout the cellular body (Fig. 1D; asterisk) and in multiple short processes (Fig. 1D; arrow). 
Also, when associated with stretched endothelial cells cellular bodies of Pdgfrb+ pericytes were thinner (Fig. 1D; 
white arrowhead) with long extensions (Fig. 1D; yellow arrowhead). There were no indications that Pdgfrb+ cells 
were positive for the anti-FAP-1 fibroblast marker (Suppl. Fig. S2E). Thirdly, Pdgfrb(BAC)-CreERT2 mice were 
crossed with a ROSA-mTmG receptor line (Suppl. Fig. S1D). ROSA-mTmG mice have a membrane-localized 
two-color fluorescence Cre reporter allele. The line expresses membrane-tdTomato fluorescence in widespread 
cells and membrane-eGFP in Cre recombinase expressing cells. The red fluorescence was expressed by the stromal 
part of the tumor; in the membrane of vascular cells (Fig. 1E; white arrowhead), circulating cells (Fig. 1E; white 
arrow, Suppl. Video S1) and infiltrated blood cells (Fig. 1E; yellow arrow). Fluorescence of eGFP was observed in 
Pdgfrb+ cells after Cre-induced recombination using tamoxifen. Membrane-localized eGFP fluorescence was less 
condense and had a more speckled appearance compared to DsRed and tdTomato fluorescence that is known to 
be soluble in the cytosol27. Due to the membrane-anchoring of the GFP protein, even small cellular protrusions 
were labeled and, accordingly, GFP+ cells appeared star-shaped (Fig. 1F; asterisk) with long extensions (Fig. 1F; 
arrow) and shorter processes (Fig. 1F; arrowhead). These star-shaped cells (Fig. 1G; asterisk) also connected to 
endothelial partners only through branches (Fig. 1G; arrow). In addition, another well-known model to study 
sprouting angiogenesis and vessel maturation is the developing retina28 and animals described in this paper can 
be used to study retinal angiogenesis as fluorescent signals were still visible after PFA fixation (Suppl. Fig. S2F,G).
Spatial association of endothelial cells and pericytes. Intravital microscopy of above described 
transgenic animals allows longitudinal spatial evaluation in thick tissue by which the position of endothelial 
cells and pericytes can be located without intervention. Endothelial tip cells (Fig. 2A; arrow) migrated into a 
vessel-poor tumor area forming an endothelial sprout. Pericytes (Fig. 2A; asterisk) invaded the non-vascularized 
area, nicely following the path of endothelial cells, however remained at a specified distance (164.3 ± 16.9 µm) 
from the endothelial front (Fig. 2B). In the established vasculature pericytes closest to an endothelial tip cell 
(Fig. 2C; arrow) were found at branching points (Fig. 2C; white arrowhead) or stretched along the endothelial 
tube (Fig. 2D; yellow arrowhead). Also these pericytes remained at a certain distance (72.9 ± 16.3 µm) from the 
endothelial tip cell (Fig. 2E). A 3D tissue reconstruction shows the intimate association of Cspg4+ pericytes with 
an endothelial tube (Suppl. Fig. S3A, Video S2). Pericytes connected to endothelial cells wrapped around the tube 
even though a single pericyte did not completely envelope the tube (Suppl. Fig. S3Ai, Aii; arrow). This is different 
from smooth muscle cells in skin tissue, which is observed to be fully wrapped around endothelial tubes (Suppl. 
Fig. S3B; arrow and Suppl. Video S3).
Temporal association of endothelial cells and pericytes. Interaction profiles of dynamic processes 
during angiogenesis are often incomplete or difficult to interpret without temporal information, certainly as sev-
eral types of specialized cells are involved (for review29). Migratory guidance of a tip cell is thought to be driven by 
stimulatory environmental cues18,30 directing the endothelial sprout, which is composed of proliferating stalk cells 
trailing behind the migrating tip cell. Phalanx endothelial cells31 are quiescent cells in the established vasculature 
and do not show any major change in movement and morphology. We observed a highly interactive cross-talk 
between endothelial cells as sprouts moved forward (Fig. 3A; white arrow, B), changed diameter (Fig. 3B), sepa-
rated into new sprouts (Fig. 3A; yellow arrow), connected with other sprouts (Fig. 3A; asterisk), and formed new 
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Figure 1. Fluorescence in endothelial cells and pericytes. (A–C) GFP Fluorescence in endothelial cells and 
DsRed in pericytes. (A) GFP fluorescence in the membrane (arrow) and golgi (asterisk) of tumor-associated 
endothelial cells. Cytosolic-DsRed fluorescence in Cspg4+ tumor-associated pericytes. (B) DsRed fluorescence 
in the pericyte body (asterisk) and pericyte processes (white arrow). (C) GFP fluorescence in long thin 
endothelial cells (yellow arrowhead). DsRed fluorescence in the pericyte body (asterisk) and long extended 
protrusions (white arrowhead). (D) GFP fluorescence in endothelial cell and Cre-induced cytosolic-tdTomato 
fluorescence in Pdgfrb+ pericytes. TdTomato fluorescence in the round pericyte body (asterisk) with short 
pericyte processes (arrow) and the more stretched body (white arrowhead) with longer protrusions (yellow 
arrowhead). (E–G) Membrane-tdTomato and Cre-induced membrane-eGFP fluorescence in Pdgfrb+ pericytes. 
(E) Tomato fluorescence in vascular cells (white arrowhead), circulating cells (white arrow) and cells in the 
tumor interstitium (yellow arrow). (F,G) GFP fluorescence in short (arrowhead) and long (arrow) pericyte 
processes and in the pericyte body (asterisk). Scale bars represent 50 µm.
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branches (Fig. 3A; arrowhead). In contradiction, pericytes hardly associated with other pericytes and migrated 
seemingly independent of each other (Fig. 3C). The distance by which endothelial cells and pericytes migrated 
forward was variable between tumors (Fig. 3D). However, intratumoral, both cell types maintained their veloc-
ity (Table 1) and pericytes followed endothelial cells at almost identical speed (Table 1, Fig. 3E), indicating that 
angiogenic pericyte behavior (Fig. 3F; asterisk) is most likely controlled by endothelial cells (Fig. 3F; arrow). In 
established vessels, phalanx endothelial cells were defined as cells that did not show any movement in the evalu-
ation period of 12 or 24 hrs. Pericytes associated with these endothelial cells also showed no significant temporal 
events (Fig. 3G; arrow). Pdgfrb+ cells detached from a vessel went into apoptosis, as indicated by the granulated 
cellular debris still expressing GFP, when unable to (re)connect to endothelial cells (Fig. 3H; arrowhead), whereas 
pericytes that are part of a vessel remained quiescent (Fig. 3H; arrow).
Morphogenetic events of endothelial cells and pericytes. Detailed evaluation of single cells and cel-
lular processes could also be performed using these animals. Continuous imaging of a progressing sprout shows 
the directionality of endothelial tip cells during migration (Fig. 4A, Suppl. Video S4). We also observed that, 
during migration, endothelial tip cells, or parts thereof, were regressing back into the stalk area. (Fig. 4B; arrow). 
Tip cells possessed long and motile filopodia scanning the environment for directional cues and GFP fluores-
cence was seen in these filopodia (Fig. 4B; arrowhead). In contrast, filopodia could not be visualized using the 
ROSA-mTmG line. Filopodia of migrating endothelial cells were as dynamic as the tip cell itself and were contin-
uously extending, retracting or even disappearing (Fig. 4C). High-resolution morphogenetic data of pericytes was 
also collected. Cellular processes, denoted as primary trunks (Fig. 4D; arrow), were seen protruding directly from 
the cellular body (Fig. 4D; asterisk). Although pericytes were as motile as endothelial cells, as shown in Fig. 3, 
pericyte trunks did not show the high dynamics of endothelial filopodia (Fig. 4E), what could indicate that these 
trunks function more for association with endothelial cells rather than migration. Pericytes were highly variable 
in morphology, which correlated with vessel diameter (Table 2). Pericytes associated with large (>30 µm diame-
ter) vessels (Suppl. Fig. S4A,C; asterisk) had more and shorter primary trunks compared to pericytes associated 
Figure 2. Spatial association of endothelial cells and pericytes. (A,B) Association in the angiogenic front 
region. (A) Endothelial tip cells (arrow) and pericytes (asterisk) association at the angiogenic front. (B) 
Quantification of pericyte – endothelial tip cell distance in the front region. (C–E) Association in the established 
region. (C,D) Close to the endothelial tip cell (arrow) pericytes are found in the branching points (white 
arrowhead) or around the tube (yellow arrow). (E) Quantification of pericyte – endothelial tip cell distance in 
the established vessel region. Data represents mean ± SEM. *p < 0.05 versus (B). Scale bars represent 100 µm.
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Figure 3. Temporal association of endothelial cells and pericytes. The first evaluation was made when 
endothelial cells and/or pericytes were clearly seen in the tumor area and re-evaluated 6, 12 and 24 hrs later. 
(A–F) Dynamics in sprouting vessels. (A) Subsequent projections of endothelial vessel dynamics. Endothelial 
sprouts invading the unvascularized tumor area (white arrow), splitting of endothelial sprouts (yellow arrow), 
connections of endothelial sprouts (asterisk), formation of new branches (arrowhead). (B) Quantification of 
sprout length and thickness in time. Each data line represents an individual sprout. (C) Subsequential single 
plane representation of endothelial cell – pericyte association. (D,E) Quantification of endothelial cell and 
pericyte migration in 3 individual tumors. Data represent mean ± SD of at least 5 cells. (F) Dynamic association 
of endothelial cells and pericytes in angiogenic vessels indicating endothelial sprouts (arrow) and adjacent 
pericytes (asterisk). (G,H) Dynamics in established vessels. (G,H) Sequential projections of endothelial cells 
and pericytes in the established vessel region indicating quiescent pericytes (arrow) closely associated with 
quiescent endothelial cells. (H) Pericytes disconnected from the vessel (arrowhead) deteriorating in time. Scale 
bars represent 100 µm.
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with vessels of an intermediate (between 30 and 10 µm) diameter and single endothelial cell (<10 µm) vessels. 
(Suppl. Fig. S4B,C; arrow).
Retrospective analysis of endothelial cell and pericyte association. As for most dynamic processes 
it is difficult to predict the onset of an event. However, multi-timed intravital imaging permits retrospective eval-
uation allowing us to investigate endothelial cell and pericyte dynamics at the start of vessel sprout formation and 
Endothelial cells Pericytes
Ratio EC:PCVelocity (nm/s) Ratio 6 hrs:12 hrs Velocity (nm/s) Ratio 6 hrs:12 hrs
Tumor 1
0–6 hrs 1.19 ± 0.11
1.1
1.49 ± 0.23
1.2 0.8
6–12 hrs 1.10 ± 0.18 1.29 ± 0.17
Tumor 2
0–6 hrs 2.43 ± 0.06
1.2
1.94 ± 0.34
1.0 1.2
6–12 hrs 2.11 ± 0.01 1.92 ± 0.28
Tumor 3
0–6 hrs 4.04 ± 0.33
1.1
3.21 ± 0.22
1.1 1.3
6–12 hrs 3.73 ± 0.31 2.82 ± 0.20
Table 1. Velocity of endothelial cells and pericytes. Z-stacks of the same tumor regions were taken of 3 different 
tumors at 0, 6 and 12 hrs. The distance of individual endothelial cells and pericytes was measured using Fiji and 
velocity was calculated by dividing the distance of cell traveled between time-point 0 hr and 6 hrs and between 
6 hrs and 12 hrs by time. Data represent mean ± SD of at least 5 cells.
Figure 4. Morphogenetic events of endothelial cells and pericytes. (A–C) Dynamics of endothelial tip cells. 
(A) Still pictures of a time-lapse movie showing a migrating endothelial tip cell. (B) Regressing endothelial 
cells (arrow) back into the stalk area and dynamics of individual filopodia (arrowhead). (C) Quantification of 
filopodia length in time. Each data line represent an individual filopodium. (D,E) Sequential images of pericyte 
dynamics. (D) Primary trunks (arrow) protruding from the pericyte cellular body (astriks) and the formation 
of a new trunk (yellow arrowhead). (E) Quantification of the length of pericyte trunks in time. Each data line 
represent an individual trunk. Scale bars represent 25 µm.
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anastomosis. At positions of emerging sprouts pericytes seemed to be absent at the exact location of endothelial 
tip cell initiation (Fig. 5A; arrow). Also, pericytes in close vicinity of the beginning endothelial sprout dispersed 
(Fig. 5A; white arrowhead) and moved away along the existing vessel. More focused experiments need to be 
done in order to confirm if this is an unrelated cellular movement or a regulated process. Judging from several 
observations, the latter is more likely as later in the angiogenic process these pericytes re-emerged (Fig. 5A; yellow 
arrowhead) and associated with stalk endothelial cells of the newly formed sprout. Through injection of a long 
circulating blood flow marker (Fig. 5B, purple channel) we could evaluate blood flow and movement of endothe-
lial cells (Fig. 5B; arrow) and pericytes (Fig. 5B; arrowhead) during anastomosis. Endothelial cells from opposite 
vessels moved towards each other and pericytes did not lose contact with endothelial cells and migrated along the 
vessel tube. Also, blood flow in these endothelial sprouts was present and is known to stimulate regulated forward 
movement32,33.
Re-evaluating the tissue after whole-mount staining. There is still much unknown about pericyte 
origin and several subpopulations are believed to exist16,34,35. Staining pericytes with different markers will be 
helpful in identify these subgroups. To re-evaluate endothelial cell – pericyte association and investigate pericyte 
identity, tumor tissue was stained as a whole-mount after intravital evaluation. A number of antibodies for peri-
cytes were tested: desmin (Fig. 6A, Suppl. Fig. S5A), NG2 (Fig. 6B), Pdgfrb (Suppl. Fig. S5B,D) and SMA (Suppl. 
Fig. S5C) and were found to stain pericytes in the dissected tumor. GFP, DsRed and mTomato fluorescence were 
still visible after fixation, bypassing the need for counterstaining. Changes in cellular morphology after fixation 
were minimal and intravitally evaluated regions were found back after staining allowing quantification of pericyte 
subpopulations in relation to their cellular morphology and vessel position (Fig. 6A; arrow). B16BL6 and LLC 
tumors are surrounded by fibrous encapsulating tissue and Pdgfrb (Suppl. Fig. 5B; asterisk) and SMA antibodies 
interacted with this tissue limiting their use for Z-stack imaging. Desmin, an intracellular intermediate filament 
protein and seen as fibers throughout the cell, worked best for whole-mount staining, as it penetrated tissue bet-
ter and gave less background. Using whole-mount staining the position of an endothelial tip cell (Fig. 6B, Suppl. 
Fig. S5A; arrow) and nearby pericyte was not compromised (Fig. 6B, Suppl. Fig. S5A; arrowhead). Of all stained 
cells 59.2 ± 15.7 percent were Pdgfrb/desmin double positive (Fig. 6C; white arrow, Fig. S6) and 81.1 ± 5.5 percent 
were Cspg4/desmin double positive (Fig. 6D; white arrow, Fig. 6E), indicating that the majority of endogenously 
stained pericytes also stained positive for a second pericyte marker.
Discussion
Several pre-clinical models are available to study angiogenesis in vivo: mouse embryos, retina, bone and tumor, 
chick corneal micropocket assay and zebrafish (for review36–38). Embryo’s, retina’s, bones and sectioned tumors 
are relative easy techniques and offer rapid, quantitative but static analysis. Chick corneal micropocket assay 
and zebrafish permit non-invasive observation and long-term monitoring. However these models represent 
non-mammalian embryonic angiogenesis and the possibility for additional staining is minimal. Intravital win-
dow models (for review39,40) are often used to investigate tumor pathophysiology and therapeutic effects41–43. 
Although tumor angiogenesis is chaotic and less controlled it features all stages of vessel development and is 
closer related to the human setting compared to chick and zebrafish models. Therefore, to study a complex bio-
logical system like angiogenesis, it is important to combine several models complementing their advantages44–46. 
In this report we demonstrate the use of several transgenic mouse lines using a developing tumor as an angiogenic 
model showing the dynamic interaction between endothelial cells and pericytes in 4D high resolution followed by 
whole-mount re-evaluation. Cross-breeding Cspg4-DsRed, as well as Pdgfrb-CreERT2 mice, with eNOStag-GFP 
animals produced offspring in which endothelial cells and pericytes were clearly distinguishable from each other. 
GFP was expressed in the Golgi, membrane and filopodia of endothelial cells allowing visualization of ingrowth 
of vessel sprouts, interactions between sprouts, progression or regression of endothelial tip cells and dynamics of 
individual filopodia. With the exception of visualizing endothelial filopodia, Pdgfrb-CreERT2 x ROS-mTmG can 
also be used although the membrane-bound eGFP gives us a less accurate representation of pericyte morphology. 
Cytosolic DsRed and tdTomato fluoresce throughout the pericyte body and processes, allowing visualization of 
morphological characteristics of pericytes. Although endogenous labeling of pericytes did not permit single cells 
perception, their more dispersed distribution made individual cell tracking possible. In these described models, 
which also allow retrospective analysis, endothelial cells and pericytes were studied in the correct spatiotemporal 
context. Appearance of an endothelial tip cell is a crucial cellular event in sprouting angiogenesis and there is a 
delicate feedback loop in the signaling pathway notch/DLL4/Jagged-1 determining which cell becomes the tip 
cell, and which cells form the new sprout; the stalk cells47,48. However the dynamic nature in tip cell replacement, 
tip/stalk cell switch and the exact involvement of directional cues are still not clear30,45,46,49–51. Simultaneously, 
Vessel diameter (range)
Pericyte trunks Pericyte branches
Number Length (µm) Number Lenght (µm)
>30 µm (74.8–31.9)#,$ 3.9 ± 0.3#,$ 12.5 ± 1.4#,$ 1.0 ± 0.3#,$ 5.4 ± 0.5
<30> 10 µm (29.1–10.5) 2.7 ± 0.2* 17.2 ± 1.5* 0.4 ± 0.3* 5.7 ± 1.2
<10 µm (8.9–3.0) 2.0 ± 0.2 35.7 ± 4.7 0 ± 0 n.a.
Table 2. Correlation between vessel diameter and pericyte morphology. Z-stacks were taken of at least 3 
different tumors and vessel diameter, number and length of pericyte trunks and branches measured. #p < 0.05 
for >30 µm versus <30> 10 µm vessels; $p < 0.05 for >30 µm versus <10 µm vessels; *p < 0.05 for <30> 10 µm 
versus <10 µm vessels. Data represents mean ± SEM of at least 3 cells in 3 different tumors. n.a. = not applicable.
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pericytes migrate, associate and disperse alongside an endothelial sprout, although whether or not pericytes guide 
these endothelial sprouts needs further investigation51–53. Sectioning of tissue, required for histology, generates 
blind ended vessels which can wrongly be interpreted as endothelial tip cells. Although whole-mount staining 
Figure 5. Retrospective analysis of pericyte detachment and recruitment. Images of vessel development taken 
at T = 0, 6, 12 and 24 hrs were re-evaluated. (A) Subsequential projection of a developing endothelial sprout 
(arrow) and an adjacent dispersing (white arrowhead) and re-emerging (yellow arrowhead) pericyte. (B) 
Forward movement of endothelial cells (arrow) and recruitment of pericytes (arrowhead) during anastomosis. 
Blood flow is detected using pegylated nanoparticles (PEG-NP) that remain in the blood circulation for 
approximately 20 hrs. Scale bars represent 50 µm.
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procedure needs intensive validation and, this is especially true for the induced Cre-line, endogenous labeling 
was not 100% of all cells, the spatial position of endothelial cells and pericytes are not compromised. Therefore, 
this model will also help investigating of signaling pathways54 in the dependency of pericytes on endothelial cells 
to migrate.
Figure 6. Re-evaluating pericytes using whole-mount staining. (A,B) Re-evaluating spatial endothelial cell –  
pericyte association. (A) Intravital images of Cspg4+ pericytes shown in Fig. 4 re-evaluated after desmin 
staining (arrow). (B) Cspg4+ pericytes re-stained with NG2 (arrowheads) shown in close proximity of 
endothelial tip cells (arrow). (C–E) Co-localization of pericyte markers. (C,D) Whole-mount staining of tumor 
tissue showed Pdgfrb+ or Cspg4+ pericytes co-expressing desmin (white arrow), Pdgfrb+ pericytes not 
stained for desmin (arrowhead), and Pdgfrb- or Cspg4- pericytes stained positive for desmin (yellow arrow). 
(E) Quantification of co-expression of Pdgfrb or Cspg4 with desmin. Data represent mean ± SEM. Scale bars 
represent 50 µm.
www.nature.com/scientificreports/
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Taken together, the mouse lines presented here, in combination with high resolution 4D imaging and 
whole-mount histology, will substantially contribute to the investigation of spatiotemporal association and 
molecular pathways of endothelial cells and pericytes during angiogenesis.
Methods
Animal work and breeding history. Animal experiments were approved by the Instantie voor 
Dierenwelzijn Erasmus MC and MPI institutional animal ethics committee and conducted with permis-
sions granted by the Nederlandse Dierexperimentencommissie and by the Landesamt für Natur, Umwelt und 
Verbraucherschutz (LANUV) of North Rhine-Westphalia, Deutschland. The experiments were performed 
according to the European directive 2010/63/eu on the protection of animals used for scientific purposes. ROSA 
reporter lines and eNOStag-GFP were bred homozygous. Cspg4-DsRed was kept hemizygous as recommended 
by the developer and the Pdgfrb(BAC)-CreERT2 line to avoid overexpression. Male Cre drivers were crossed with 
a female reporter or female eNOStag-GFP. All breeding combinations produced in general a standard number of 
offspring and male/female ratio. No harmful phenotype was observed in breeding animals and their experimental 
offspring. Also Cre-induction using tamoxifen showed no toxicity.
Generation of the animals. The eNOStag-GFP mouse is a variation of the eNOS-GFP line, which has an 
elevated eNOS level55. In the tag line, a truncated eNOS, maintaining the localization pattern however losing the 
ability to overproduce eNOS, is fused to GFP (Suppl. Fig. S1a). To ensure protein expression, a DNA fragment 
containing a 6.3 kb promoter sequence and 123 bp of the first human eNOS gene exon were isolated from a 
home-made human cosmid library and fused in frame with GFP cDNA. This DNA was injected into fertilized 
FVB/n donor oocytes and transplanted into oviducts of pseudopregnant B16xCBA mice. A cDNA encoding 
tamoxifen-inducible Cre recombinase (Suppl. Fig. S1b) followed by a polyadenylation signal sequence and a 
FRT-flanked ampicillin resistance cassette were introduced by recombination of the start codon of Pdgfrb in the 
bacterial artificial chromosome clone RP24-62H17TJ (BACPAC Resources Center, Children’s Hospital Oakland 
Research Institute). After Flp-mediated excision of the ampicillin resistance cassette in bacteria, the resulting 
constructs were validated by PCR analysis and used in circular form for pronuclear injection into fertilized mouse 
oocytes56.
The genotype of eNOStag-GFP mice was determined by polymerase chain reaction using the follow-
ing primers; GFP-Forward, 5-AGCTGACCCTGAAGTTCATCTG-3; GFP-Revers, 5-GACGTTGTGGCTG 
TTGTAGTTG-3. The reaction was performed on toe or ear DNA for 35 cycles at 30 seconds at 94 °C, 60 sec-
onds at 65 °C and 60 seconds at 72 °C and produced a product of 300 bp. For the genotyping of the Cre-line 
the following primers were used; Cre-Forward, 5-GTGGCAGATGGCGCGGCAACACCATT-3; Cre-Revers, 
5-GCCTGCATTACCGGTCGATGCAACGA-3. The thermal profile was 30 seconds at 94 °C, 72 seconds 
at 65 °C and 60 seconds at 72 °C for 35 cycles producing a product of 720 bp. Cspg4-DsRed (stock 008241), 
ROSA-mtdTomato-meGFP (ROSA-mTmG; stock 007676), ROSA-tdTomato (stock 007914) mice were pur-
chased from Jackson laboratory. To create experimental offspring, eNOStag-GFP animals were crossed with 
Cspg4-DsRed mice (Suppl. Fig. S1c) and Pdgfrb(BAC)-CreERT2 with ROSA-mTmG (Suppl. Fig. S1d). For triple 
transgenic mice a Pdgfrb(BAC)-CreERT2 x ROSA-tdTomato line was first created after which the males were 
crosses with eNOStag-GFP females (Suppl. Fig. S1e). All animals were kept on a C57bl/6 background.
Cre Induction. Tamoxifen (Sigma Aldrich) was dissolved in ethanol/peanut oil (1/3) mixture at a concentra-
tion of 10 mg/ml. This was further diluted 1/10 in peanut oil and 50 µl was injected into the pup at postnatal day 1 
and 2. Animals were allowed to age for dorsal skinfold transplantation (Suppl. Fig. S1f).
Dorsal skinfold transplantation. Murine melanoma B16BL6 and Lewis lung carcinoma (LLC) cells were 
maintained in DMEM medium and 10% heat-inactivated fetal calf serum. Subcutaneous tumors were generated 
by injecting 1 × 106 tumor cells in the flank of a wildtype animal under isoflurane inhalation anesthesia. This 
tumor was used for transplantation into the dorsal skinfold. Preparation of tumor implantation in the dorsal 
skinfold chamber is previously described41,57 and performed on mice of 10 weeks old and at least 20 g (Suppl. 
Fig. S1F). Briefly, mice were anesthetized using isoflurane inhalation anesthesia and hair was removed from 
the back of the animal. After dissecting the skin, leaving fascia and opposing skin intact, the skinfold of the 
mouse was sandwiched between two frames, fixed with two light metal bolts and sutures. A small piece of tumor 
(0.1 mm3), obtained from the wildtype bulk animal, was transplanted in the fascia. The backside was closed with 
a 10 mm filler glass and standard 12 mm diameter microscopic glass and the front with a 12 mm photoetched grid 
glass (Electron Microscopy Science, USA). The glasses are held in place with a thin metal ring. The mice were 
individually housed in an incubation room with an ambient temperature of 30 °C and a humidity of 70%.
Intravital evaluation. The ingrowth of tumor vessels into B16BL6 and LLC tumors started around 7 days 
after implantation and took 10 to 13 days to form a complete functional vasculature. For intravital confocal 
microscopy, mice were anesthetized using isoflurane inhalation anesthesia and placed on a heated stage of a 
Leica SP5 multiphoton microscope (Leica Microsystems)57. As tumors were obtained from a wildtype animal all 
fluorescent cells were indicative to the host. To perceive blood flow, animals were injected with pegylated nano-
particles labeled with a far-red fluorescent marker58 which stays in the blood circulation for approximately 20 hrs 
and/or with 30 µl Hoechst 33342 (Sigma Aldrich; 10 mg/ml), a small molecule that is taken up by living cells.
Whole-mount staining. After intravital evaluation, the glass of the window was carefully removed and the 
tumor tissue was stained as a whole-mount allowing extra identification of intravitally evaluated pericytes. The 
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tumor was fixed in 4% paraformaldehyde (PFA), permeabilized, stained with rabbit anti desmin (Abcam), guinea 
pig anti NG2 (kindly donated by Prof. Stallcup), rat anti Pdgfrb (eBioscience) or mouse anti SMA-Cy3 (Sigma 
Aldrich) and, dependent on the already endogenous fluorescence, counterstained with a corresponding second-
ary Alexa Fluor 561 or 643 antibody (Molecular Probes) and DAPI (Sigma Aldrich). The tissue was mounted 
using glycerol/gelatin (Sigma Aldrich) in CoverWell imaging chambers (Sigma Aldrich) and evaluated using a 
Leica SP5 multiphoton microscope.
Imaging and representation. Imaging, intravital57 as well as histological, was performed using a Leica SP5 
multiphoton microscope. For intravital microscopy, an APO 10.0 (NA 0.4) or APO 20.0 (NA 0.5) dry objective 
lens and, for histology, an APO 10.0 (NA 0.4) dry, APO 20.0 (NA 0.7) dry or an APO 40.0 (NA1.25–0.75) oil lens 
were used. Fluorescence was excited with a 405 nm diode, 488 nm argon, 543 nm and 633 nm helium-neon laser. 
The reflection of the grid etched in the cover glass was used as a reference point for multi-time imaging. Unless 
mentioned otherwise, images are presented in the results section as maximal projection of a single tile Z-stack.
Analysis of pericyte morphology. Determining pericyte morphology was performed by making 3D 
reconstruction from high-resolution confocal stacks using Amira software. The morphological characteristics of 
individual pericytes is based on a report by Hartmann et al.13 in which pericytes are morphologically evaluated 
in brain tissue as this corresponds to morphological features seen in the tumor. The pericyte cellular body was 
identified by the presence of the nuclei visualized by Hoechst or DAPI, primary trunks as cellular processes pro-
truding directly from the cellular body and primary branches as thin singular stands splitting from the primary 
trunk. Care was taken to only analyze isolated pericytes and processes longer than 3 µm were counted.
Data analysis. Fiji (Wayne Rasband, NIH) was used for data analysis. Dynamic vessel sprout length was 
established by measuring the length between tip of the vessel and first branching point. Subcellular length of 
endothelial filopodia and pericyte processes was established by measuring the length between tip of the filopo-
dia/process and center of the cellular body. Images taken at time-point 0, 6, 12 and 24 hrs were used to measure 
migration distance and velocity of individual cells. At time-point 0 hr cells were selected and traced in the fol-
lowing images. Velocity was calculated by dividing the recorded distance by time. To determine co-expression of 
pericyte markers, co-labeled cells were traced throughout the channels of the individual images of the Z-stack, 
using the nuclear staining to identify single cells and were counted manually.
Statistics. Results were evaluated for statistical significance with the Mann Whitney U test using IBM SPSS 
Statistics 21. P-values below 0.05 were considered statistically significant. Data was obtained from at least 3 indi-
vidual experiments.
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